mercredi 21 mars 2012

Life Technologies Exclusive Distributor for CEERAM qPCR kits in Europe, Middle East & Africa

Deal widens breadth of fast, accurate tests for food-borne viruses

Glasgow, UK, March 8, 2012—Life Technologies today announced it has become the exclusive distributor in Europe, Middle East & Africa for CEERAM molecular tests that are designed to quickly and accurately detect the presence of food-borne viruses.
Up until now the kits, Norovirus GI and Norovirus GIIHepatitis A and Mengovirus, have been sold mainly by CEERAM worldwide to major food manufacturers and service laboratories to help reduce the risk of contamination.
“Considering the rise of high-profile virus outbreaks in the last year alone, it’s clear that rapid and accurate molecular tests are paramount to keep widespread contamination away from consumers,” said Benoit Lebeau, CEO of The European Centre for Expertise and Research on Microbial Agents (CEERAM).

Life Technologies has developed highly accurate and rapid testing solutions for a broad range of food products and environmental samples since 2008. It has done so by using its whole genome sequencing capabilities to design its assays. AFNOR and AOAC certification for its top four products, MicroSEQ® Listeria spp. Listeria monocytogenes, MicroSEQ® Salmonella spp. and E.coli O157:H7 applies to the assays, the sample preparation workflow, the real-time PCR instrumentation and the data interpreting software.
Not for use in human or animal diagnostic procedures.

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers
in more than 160 countries using its innovative solutions to solve some of today’s most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy- to-use solutions spanning the biological spectrum with more than 50,000 products for translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion TorrentTM, Applied Biosystems®, InvitrogenTM, GIBCO®, Ambion, Molecular Probes®, Novex®, and TaqMan®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011.
Visit us at our website:

Life Technologies’ Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward- looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

CEERAM, The European Centre for Expertise and Research on Microbial Agents, is an independent, innovative laboratory specialising in the genetic identification (DNA/RNA) of viruses, bacteria, parasites and fungi. The company was created by Benoît Lebeau (CEO) and Fabienne Loisy-Hamon (Scientific Director).

Media Contact : David Robertson
Life Technologies  +44 141 814 5889 

Aucun commentaire: